Luis Rafael Moscote Salazar | Medicine and Health Sciences | Best Academic Researcher Award

Published on by Innovation Technologist

Best Academic Researcher Award

Luis Rafael Moscote Salazar
AV Healthcare Innovators, LLC, United States

Luis Rafael Moscote Salazar
Affiliation AV Healthcare Innovators, LLC
Country United States
Scopus ID 59157644400
Documents 338
Citations 1,911
h-index 21
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-4180-6962

Luis Rafael Moscote Salazar is a researcher associated with AV Healthcare Innovators, LLC, United States, whose academic profile is situated within medicine and health sciences. His documented research record includes contributions addressing neurological conditions, neurotrauma, intensive care, and emerging questions in clinical medicine. With 338 indexed documents, 1,911 citations, and an h-index of 21, his supplied Scopus profile provides quantitative indicators for examining research productivity and scholarly visibility. His profile is considered in the context of the Best Academic Researcher Award under the Global Innovation Technologist Awards. [1]

Abstract

This academic profile presents the research activities and scholarly indicators of Luis Rafael Moscote Salazar in medicine and health sciences. His publication record encompasses neurotrauma, neurointensive care, neurological emergencies, and the broader intersection of clinical medicine and scientific innovation. Three identified research contributions address brain tamponade, shivering management during targeted temperature management, and the implications of microgravity for neurotrauma. These subjects demonstrate the relevance of neurological research to contemporary clinical practice and emerging medical challenges. Bibliometric indicators and publication records provide a foundation for considering his academic profile within an international research recognition framework.

Keywords

Luis Rafael Moscote Salazar; Best Academic Researcher Award; neurotrauma; neurointensive care; brain injury; targeted temperature management; neurological research; space medicine; clinical innovation; medicine and health sciences.

Introduction

Medical research contributes to the development of diagnostic approaches, clinical management frameworks, and improved understanding of complex neurological conditions. Neurotrauma represents an important research area because traumatic and critical neurological conditions frequently require coordinated assessment, intensive monitoring, and evidence-informed intervention.

Researcher evaluation therefore benefits from considering publication productivity alongside subject relevance, citation performance, and the practical significance of individual research contributions. The present profile organizes available information about Moscote Salazar using these complementary perspectives. [2]

Research Profile

The researcher’s identified subject area is medicine and health sciences, with particular relevance to neurological and neurocritical care topics. His supplied Scopus profile records 338 documents and 1,911 citations, with an h-index of 21. These indicators offer different perspectives: document counts reflect indexed research output, citations indicate scholarly referencing, and the h-index combines productivity with citation distribution. [1]

His ORCID identifier, 0000-0002-4180-6962, provides an additional researcher identification reference for distinguishing scholarly contributions across academic platforms. [2]

Research Contributions

The identified publications address three complementary research directions:

  • Neurotrauma and space medicine: examining potential implications of microgravity for neurological injury and human space exploration.
  • Neurological emergencies: discussing the definition, pathophysiology, and proposed classification of brain tamponade.
  • Neurointensive care: presenting the SHIVER framework for managing shivering during targeted temperature management.

Together, these topics connect neurological pathophysiology with clinical management and emerging healthcare environments. [3] [4] [5]

Publications

Three supplied journal articles illustrate the researcher’s identified interests:

  1. Microgravity and Neurotrauma: Implications for Space Medicine and Human Space Exploration. Indian Journal of Neurotrauma. December 2026.
  2. Brain Tamponade: Definition, Pathophysiology, and Proposal for Classification. Journal of Neurointensive Care. October 31, 2026.
  3. SHIVER – A Practical Framework for the Management of Shivering During Targeted Temperature Management. Journal of Neurointensive Care. October 31, 2026.

Research Impact

The reported 1,911 citations and h-index of 21 provide quantitative evidence of scholarly visibility within indexed academic literature. However, citation indicators should be interpreted alongside research quality, authorship contributions, publication context, and clinical relevance. The identified work on neurointensive care and neurotrauma addresses subjects with potential significance for neurological treatment strategies, critical care education, and future research development. [1]

Award Suitability

The Best Academic Researcher Award recognizes scholarly productivity, research contributions, and academic impact across disciplines. Moscote Salazar’s supplied bibliometric indicators and identified publications provide relevant material for assessment under the Global Innovation Technologist Awards. Consideration may include publication quality, citation performance, research originality, methodological contribution, and potential clinical relevance. Final recognition should be determined through the award programme’s applicable evaluation and verification procedures.

Conclusion

Luis Rafael Moscote Salazar’s academic profile reflects an established publication record in medicine and health sciences, particularly in neurological research and neurointensive care. His documented scholarly indicators and identified publications provide a basis for evaluating research productivity, academic visibility, and contributions to contemporary medical knowledge. His profile represents a relevant subject for consideration within the Best Academic Researcher Award category of the Global Innovation Technologist Awards.

References

  1. Elsevier. (n.d.). Scopus author details: Luis Rafael Moscote Salazar, Author ID 59157644400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59157644400
  2. ORCID. (n.d.). Luis Rafael Moscote Salazar: Researcher identifier 0000-0002-4180-6962.
    https://orcid.org/0000-0002-4180-6962
  3. Moscote Salazar, L. R. (2026). Microgravity and Neurotrauma: Implications for Space Medicine and Human Space Exploration. Indian Journal of Neurotrauma.
    https://doi.org/10.1055/s-0046-1819573
  4. Moscote Salazar, L. R. (2026). Brain Tamponade: Definition, Pathophysiology, and Proposal for Classification. Journal of Neurointensive Care.
    https://doi.org/10.32587/jnic.2025.00920
  5. Moscote Salazar, L. R. (2026). SHIVER – A Practical Framework for the Management of Shivering During Targeted Temperature Management. Journal of Neurointensive Care.
    https://doi.org/10.32587/jnic.2026.00983
  6. Global Innovation Technologist Awards. (n.d.). Official Awards Website.
    innovationtechnologist.com

Maria D. Chermá | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Maria D. Chermá
Linköping University, Sweden

Maria D. Chermá
Affiliation Linköping University
Country Sweden
Scopus ID 6507872208
Documents 13
Citations 181
h-index 8
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0003-0209-9967

Maria D. Chermá is a researcher associated with the Swedish academic and forensic science research environment. Her publication record reflects contributions to forensic toxicology, analytical chemistry, pharmacokinetics and the investigation of drug metabolism. Her research addresses scientific questions relevant to the detection, interpretation and evaluation of substances in biological specimens. Her documented publications and bibliometric indicators provide the foundation for recognition under the Best Researcher Award category.

Abstract

This academic recognition profile presents Maria D. Chermá’s research activities in medicine and health sciences, with particular emphasis on forensic toxicology and pharmacokinetic investigations. Her scholarly work includes studies examining anabolic androgenic steroids, zopiclone and oxycodone. These subjects demonstrate the relevance of analytical measurement and drug metabolism research to forensic interpretation and public health. The profile considers publication contributions, research visibility and documented academic indicators in relation to the Best Researcher Award.

Keywords

Forensic toxicology; pharmacokinetics; analytical chemistry; drug metabolism; mass spectrometry; substance use; medicine and health sciences; biological specimens; toxicological analysis.

Introduction

Forensic toxicology contributes to healthcare, criminal investigations and scientific understanding of substance exposure. Reliable identification and interpretation of drugs and their metabolites require validated analytical approaches and knowledge of pharmacokinetic processes. Chermá’s identified publications address these interconnected areas through investigations involving biological samples and drug-related measurements. Her work illustrates the importance of combining laboratory research with scientifically supported interpretation of toxicological findings.[3][4]

Research Profile

Her research profile is associated with analytical and forensic investigations of pharmaceutical and other substances. The supplied bibliometric information records 13 documents, 181 citations and an h-index of 8. These indicators offer quantitative perspectives on publication activity and citation visibility. They should be interpreted alongside research quality, methodological relevance, individual contributions and the scientific significance of published findings. Her ORCID identifier provides an additional means of distinguishing her scholarly record.[1][2]

Research Contributions

The identified research themes include:

  • Investigation of anabolic androgenic steroid use within a Swedish forensic population.
  • Pharmacokinetic evaluation of zopiclone and metabolite-to-parent ratios for estimating intake timing.
  • Examination of oxycodone pharmacokinetics and its phase I and phase II metabolites using LC–MS-MS.

Together, these topics demonstrate the importance of analytical toxicology in understanding substance exposure, metabolism and evidence interpretation.[3][4][5]

Publications

Three identified publications illustrate the breadth and continuity of her research interests:

  1. Use of anabolic androgenic steroids in a Swedish forensic population: Associations with substance use and criminal convictions. Drug and Alcohol Dependence, October 2026.
  2. Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake. Journal of Analytical Toxicology, 2026.[4]
  3. Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS. Journal of Analytical Toxicology, 2022.[5]

Research Impact

The reported 181 citations and h-index of 8 indicate measurable scholarly visibility. The publication topics also connect laboratory-based research with practical forensic applications, particularly drug identification, exposure assessment and interpretation of biological measurements. Such contributions are relevant to the continuing development of analytical methods and evidence-based toxicological practice. Citation indicators provide useful context but do not independently establish research quality or societal impact.

Award Suitability

Maria D. Chermá’s documented research themes, publication activity and reported citation indicators provide relevant considerations for the Best Researcher Award under the Medicine and Health Sciences category. Her work addresses scientifically important questions in forensic toxicology and pharmacokinetics. The Global Innovation Technologist Awards recognize research contributions, scholarly development and the advancement of knowledge across disciplines. Final award assessment should consider verified authorship, individual research responsibilities and the applicable evaluation criteria.

Conclusion

Maria D. Chermá’s academic profile reflects research engagement in forensic toxicology, analytical chemistry and pharmacokinetic science. Her identified publications address drug metabolism and toxicological investigations with relevance to medicine and forensic applications. The reported bibliometric indicators and documented research themes establish a foundation for consideration in the Best Researcher Award category of the Global Innovation Technologist Awards. Her profile represents the contribution of analytical research to scientific understanding and evidence-based practice.

References

  1. Elsevier. (n.d.). Scopus author details: Maria D. Chermá, Author ID 6507872208. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6507872208
  2. ORCID. (n.d.). Maria D. Chermá: ORCID researcher identifier.
    https://orcid.org/0000-0003-0209-9967
  3. Chermá, M. D., et al. (2026). Use of anabolic androgenic steroids in a Swedish forensic population: Associations with substance use and criminal convictions. Drug and Alcohol Dependence.
    https://doi.org/10.1016/j.drugalcdep.2026.113410
  4. Gomonit, M. M., Nilsson, G. H., Nyström, I., Berglund, L., Kugelberg, F. C., Chermá, M. D., et al. (2026). Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake. Journal of Analytical Toxicology, 50(6).
    https://doi.org/10.1093/jat/bkag032
  5. Truver, M. T., Jakobsson, G., Chermá, M. D., Swortwood, M. J., Gréen, H., & Kronstrand, R. (2022). Urinary Pharmacokinetics of Immediate and Controlled Release Oxycodone and its Phase I and II Metabolites Using LC–MS-MS. Journal of Analytical Toxicology, 46(9), 1025–1031.
    https://doi.org/10.1093/jat/bkab123
  6. National Library of Medicine. (2026). Blood pharmacokinetics and use of metabolite-to-parent ratios to predict time of last zopiclone intake.

Jun Hu | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Jun Hu
The First Affiliated Hospital of Shantou University Medical College, China

Jun Hu
Affiliation The First Affiliated Hospital of Shantou University Medical College
Country China
Scopus ID 55712134300
Documents 39
Citations 651
h-index 15
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-1864-4862

Jun Hu is a medical researcher affiliated with The First Affiliated Hospital of Shantou University Medical College, China. His reported scholarly record includes 39 documents, 651 citations and an h-index of 15. These bibliometric indicators provide a quantitative overview of publication activity and citation visibility. His documented publications address clinical questions involving knee osteoarthritis, disparities in treatment outcomes and serious bacterial infections. The Best Researcher Award profile highlights these research contributions within the Medicine and Health Sciences subject area.

Abstract

This academic recognition profile summarizes Jun Hu’s reported research metrics and two 2026 journal articles concerning musculoskeletal health disparities and severe infectious disease. The publications illustrate distinct clinical research themes, including differences in pain and arthroplasty outcomes across racial groups and case-based reporting of group A β-hemolytic streptococcal infection associated with purpura fulminans. Bibliometric figures are presented as supplied and should be checked against the current Scopus author record. [1] [2]

Keywords

Jun Hu; Best Researcher Award; clinical research; medicine; health sciences; knee osteoarthritis; total knee arthroplasty; racial disparities; group A β-hemolytic streptococcus; purpura fulminans; bibliometrics.

Introduction

Medical research contributes to evidence-based practice by examining disease patterns, clinical outcomes and challenges affecting patient care. Research on osteoarthritis can help clarify variation in pain and access to joint replacement, while infectious disease case reports can document serious presentations that warrant clinical attention. Hu’s supplied publication records represent these complementary areas of investigation. The available information supports a focused account of the named studies but does not establish their individual methods or findings beyond the bibliographic details provided. [2] [3]

Research Profile

Hu’s reported scholarly profile comprises 39 documents, 651 citations and an h-index of 15. Together, these indicators describe publication volume, citation activity and a balance of productivity and citation reach. They should be interpreted alongside research quality, authorship contributions, methodological rigor and clinical relevance rather than as standalone measures of merit. His listed affiliation provides institutional context for the recognition profile. The supplied records do not establish a comprehensive account of his research appointments, specialist training or leadership responsibilities.

Research Contributions

The two supplied publications identify different clinical questions. The osteoarthritis article explicitly addresses racial disparities in pain and total knee arthroplasty across disease phenotypes. The infectious disease article reports two cases involving group A β-hemolytic streptococcus and purpura fulminans. Considered together, these topics concern both variation in musculoskeletal care and the documentation of severe infection. Their precise implications require interpretation of the full articles, including study design, results, limitations and clinical context. [2] [3]

Publications

  1. “Racial disparities in pain and total knee arthroplasty across knee osteoarthritis phenotypes.” Frontiers in Aging, published 20 May 2026. [2]
  2. “Group A β-hemolytic streptococcus causing purpura fulminans: two case reports.” Frontiers in Immunology, published 10 February 2026. [3]

Research Impact

The reported citation count and h-index indicate measurable scholarly visibility, although citation totals vary over time and across databases. The listed articles address subjects relevant to clinical research and patient care. A robust assessment of impact would additionally examine citation context, independent uptake, methodological quality, reproducibility and evidence of influence on clinical practice. No specific patient outcomes or changes to medical guidelines can be inferred from the bibliographic information alone. [1]

Award Suitability

The supplied publication record and bibliometric indicators provide relevant material for consideration under the Best Researcher Award at the Global Innovation Technologist Awards. A balanced evaluation should consider originality, the nominee’s verified contribution to each publication, research integrity, clinical relevance and independent evidence of impact. This profile summarizes submitted information and does not itself constitute independent verification or confirmation of an award decision.

Conclusion

Jun Hu’s reported research profile combines established bibliometric indicators with publications addressing osteoarthritis-related disparities and severe bacterial infection. These records provide a basis for reviewing his scholarly activity in medicine and health sciences. Verification of author identity, publication attribution and current citation data remains important for a complete and transparent recognition assessment.

References

  1. Elsevier. (n.d.). Scopus author details: Jun Hu, Author ID 55712134300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55712134300
  2. Frontiers. (2026). Racial disparities in pain and total knee arthroplasty across knee osteoarthritis phenotypes. Frontiers in Aging. DOI: 10.3389/fragi.2026.1819274.
    https://doi.org/10.3389/fragi.2026.1819274
  3. Frontiers. (2026). Group A β-hemolytic streptococcus causing purpura fulminans: two case reports. Frontiers in Immunology. DOI: 10.3389/fimmu.2026.1659910.
    https://doi.org/10.3389/fimmu.2026.1659910
  4. ORCID. (n.d.). Jun Hu: ORCID researcher identifier.
    https://orcid.org/0000-0002-1864-4862
  5. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Mercedes Cao Vilariño | Medicine and Health Sciences | Research Excellence Award

Published on by Innovation Technologist

Research Excellence Award

Mercedes Cao Vilariño
Universitary Hospital, Spain

Mercedes Cao Vilariño
Affiliation Universitary Hospital
Country Spain
Scopus ID 57195055799
Documents 5
Citations 15
h-index 3
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards

Mercedes Cao Vilariño is a researcher associated with medical and health sciences in Spain. Her documented research includes a 2020 publication examining smoking cessation support and carbon monoxide monitoring among kidney transplant patients who smoke. This article presents a research profile and recognition overview for the Research Excellence Award associated with the Global Innovation Technologist Awards. The available bibliographic information and supplied research metrics provide the basis for this summary; further verification is needed to establish a comprehensive publication record and award decision.

Abstract

This profile summarizes the supplied academic indicators and a reported clinical research publication associated with Mercedes Cao Vilariño. The study concerns a randomized clinical trial investigating carbon monoxide monitoring using CO-oximetry and brief anti-smoking advice for kidney transplant recipients who smoke. The topic connects preventive healthcare, tobacco cessation, and the management of health risks in transplant populations. Supplied bibliometric figures list five documents, 15 citations, and an h-index of three; these values should be interpreted according to the source and date of retrieval. [1] [2]

Keywords

Mercedes Cao Vilariño; medicine and health sciences; kidney transplantation; smoking cessation; CO-oximetry; clinical research; preventive medicine; research impact; research excellence.

Introduction

Research excellence in healthcare involves the systematic investigation of clinical questions, evaluation of evidence, and potential translation of findings into practice. Smoking cessation is particularly relevant to patients with complex medical histories, including kidney transplant recipients. Research into brief interventions and objective monitoring methods may inform approaches to identifying tobacco use and supporting cessation. The listed publication provides a specific bibliographic point of reference for understanding this research area. [1]

Research Profile

The supplied profile associates the researcher with a hospital institution in Spain and the subject area of medicine and health sciences. The Scopus author identifier provides a route to reviewing indexed publications and associated citation records. Affiliation details, author-name variants, and profile metrics may change over time; institutional and database records should therefore be consulted for current verification. [2]

Research Contributions

The identified clinical trial addresses two components of smoking-related care: carbon monoxide assessment and brief anti-smoking advice. Its focus on kidney transplant recipients places the investigation within a specialized clinical population. The study title indicates a randomized trial design, although detailed conclusions, sample characteristics, and outcome estimates should be drawn from the full publication rather than inferred from bibliographic metadata alone. [1]

Publications

The supplied record identifies the following publication:

  • “Randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke.” International Journal of Medical Sciences, 2020. The supplied record lists Mercedes Cao Vilariño among the authors. [1]

Research Impact

The supplied indicators report five documents, 15 citations, and an h-index of three. Citation counts offer one measure of scholarly visibility, but they do not independently establish research quality, clinical effectiveness, or societal benefit. A fuller assessment would consider study design, methodological rigor, reproducibility, collaboration, and relevance to patient care. These indicators should be checked against the current Scopus record before formal publication. [2]

Award Suitability

The Research Excellence Award profile highlights a documented contribution to clinical research relevant to tobacco cessation and transplant care. Consideration for recognition may include verified publications, methodological contributions, independent evidence of impact, and the candidate’s wider research record. This profile describes award-related recognition context and does not, by itself, confirm that an award has been formally conferred.

Conclusion

Mercedes Cao Vilariño’s supplied research profile includes a clinical publication on smoking-related intervention in kidney transplant patients. The reported bibliometric indicators offer a concise snapshot of scholarly activity, while a complete evaluation requires examination of the publication, current author records, and broader evidence of research contribution. Accurate attribution and transparent verification remain essential to responsible academic recognition.

References

  1. Seijo-Bestilleiro, R., Seoane-Pillado, M. T., Pértega-Díaz, S. D., Cao Vilariño, M., Gil-Guillén, V. F., et al. (2020). Randomized clinical trial to determine the effectiveness of CO-oximetry and anti-smoking brief advice in a cohort of kidney transplant patients who smoke.
  2. Elsevier. (n.d.). Scopus author details: Mercedes Cao Vilariño, Author ID 57195055799. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57195055799
  3. International Journal of Medical Sciences. (2020). Journal publication record for the randomized clinical trial on CO-oximetry and smoking cessation advice in kidney transplant patients.
  4. Global Innovation Technologist Awards. (n.d.). Official awards website.
    innovationtechnologist.com/

Hiroyuki Kinoshita | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Hiroyuki Kinoshita
Tokushima University, Japan

Hiroyuki Kinoshita
Affiliation Tokushima University
Country Japan
Scopus ID 56214100600
Documents 187
Citations 1,816
h-index 24
Subject area Medicine and Health Sciences
Event Global Innovation Technologist Awards

The Best Researcher Award profile recognizes the scholarly work of Hiroyuki Kinoshita, affiliated with Tokushima University in Japan. His reported research record includes 187 documents, 1,816 citations, and an h-index of 24. These bibliometric indicators provide a quantitative overview of publication activity and citation influence within the indexed scholarly literature. This profile highlights his documented contributions to medicine and health sciences, including recent publications concerning perioperative management and pediatric anesthesia. [1] [2]

Abstract

Hiroyuki Kinoshita is a medical researcher associated with Tokushima University, Japan. The supplied bibliometric information reports 187 scholarly documents, 1,816 citations, and an h-index of 24. Two identified 2026 publications concern the perioperative management of severe hypermagnesemia following magnesium-containing laxative overdose and perfusion-based targets in pediatric anesthesia. These topics reflect clinical interests in perioperative safety, physiological assessment, and evidence-informed anesthetic care. The profile summarizes the available information without inferring unverified research outcomes or institutional honors. [1] [2]

Keywords

Hiroyuki Kinoshita; Tokushima University; medicine and health sciences; anesthesiology; perioperative management; pediatric anesthesia; hypermagnesemia; research impact; citation analysis; Best Researcher Award.

Introduction

Clinical research supports the development of safer medical practices by examining complications, evaluating physiological responses, and informing treatment decisions. Within this context, anesthesiology research addresses patient assessment and management before, during, and after medical procedures. Kinoshita’s two supplied publication records from 2026 provide specific examples of research addressing perioperative clinical challenges. [1] [2]

Research Profile

The supplied Scopus profile identifies the researcher through author ID 56214100600. His reported record of 187 documents and 1,816 citations provides a snapshot of scholarly output and citation activity. An h-index of 24 indicates at least 24 indexed publications with at least 24 citations each, assuming the figures refer to the same dataset and retrieval date. Bibliometric values can change as databases are updated. [3]

Research Contributions

The available article records identify two clinical research topics:

  • Perioperative management following cardiac arrest associated with severe hypermagnesemia caused by magnesium-containing laxative overdose, presented as a case report in Renal Replacement Therapy in 2026. [1]
  • Perfusion-based targets in pediatric anesthesia, discussed in the 2026 article “Bridging the Gap: From Statistical Thresholds to Perfusion-Based Targets in Pediatric Anesthesia.” [2]

These subjects concern clinical decision-making and patient safety. The supplied records do not provide sufficient full-text evidence to assess the studies’ detailed methods or clinical conclusions.

Publications

The identified 2026 publications are relevant examples of the researcher’s reported scholarly activity. The first is a case report published in Renal Replacement Therapy; the second appears in Anesthesia and Analgesia. Complete DOI identifiers were not included in the supplied records and are therefore not reproduced here. The Scopus author profile provides a starting point for verifying the broader publication list. [3]

Research Impact

The reported citation count and h-index offer complementary indicators of scholarly visibility. Citations measure references received by indexed publications, while the h-index combines publication volume with citation frequency. Neither measure independently establishes clinical effectiveness, methodological quality, or societal benefit. A balanced evaluation should also consider research originality, reproducibility, collaboration, and relevance to healthcare practice. [4]

Award Suitability

The Best Researcher Award profile, presented in connection with the Global Innovation Technologist Awards, summarizes indicators relevant to scholarly recognition. The reported publication and citation metrics, together with the two identified clinical research topics, provide a basis for further assessment. A formal award decision should additionally examine verified publication records, author contributions, research quality, and alignment with the award’s published criteria. This profile does not itself establish that an award has been conferred.

Conclusion

Hiroyuki Kinoshita’s supplied research profile documents substantial publication and citation activity in medicine and health sciences. His identified 2026 publications address perioperative management and pediatric anesthesia, illustrating clinically oriented research topics. Further evaluation using verified bibliographic records and full-text publications would provide a stronger basis for assessing research quality and award suitability.

References

  1. Anezaki, H., Kawashima, S., Kobayashi, A., et al., including Kinoshita, H. (2026). Perioperative management in a patient immediately after cardiac arrest caused by severe hypermagnesemia due to magnesium-containing laxative overdose: a case report. Renal Replacement Therapy.
  2. Kawashima, S., Kobayashi, A., Kawashima, W., Kinoshita, H., et al. (2026). Bridging the Gap: From Statistical Thresholds to Perfusion-Based Targets in Pediatric Anesthesia. Anesthesia and Analgesia.
  3. Elsevier. (n.d.). Scopus author details: Hiroyuki Kinoshita, Author ID 56214100600. Scopus. Bibliometric values reproduced from the supplied profile information.
    https://www.scopus.com/authid/detail.uri?authorId=56214100600
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. Proceedings of the National Academy of Sciences, 102(46), 16569–16572.
    https://doi.org/10.1073/pnas.0507655102
  5. Global Innovation Technologist Awards. (n.d.). Official website. Award information and organizational details. innovationtechnologist.com

Paolo Gallo | Medicine and Health Sciences | Best Paper Award

Published on by Innovation Technologist

Best Paper Award

Paolo Gallo
Bio-Medico Campus University Hospital, Italy

                     Paolo Gallo
Affiliation Bio-Medico Campus University Hospital
Country Italy
Scopus ID 7101785311
Documents 95
Citations 1,878
h-index 25
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0001-8292-1134

The Best Paper Award recognizes scholarly work that contributes to research development, scientific understanding, and evidence-informed practice. This profile presents Paolo Gallo’s reported bibliometric indicators and selected publications concerning muscle assessment, sarcopenia, and prognostication in chronic liver disease. The recognition is associated with the Global Innovation Technologist Awards and the subject area of Medicine and Health Sciences. Publication details and identifiers provide pathways for readers to examine the underlying research.

Abstract

This academic recognition profile highlights research addressing muscle strength, body composition assessment, and clinical outcomes in chronic liver disease. The selected publications examine potential approaches to identifying sarcopenia and evaluating its prognostic significance in patients with cirrhosis and hepatocellular carcinoma. These topics connect clinical measurement with risk assessment and patient management. The profile combines the supplied publication records with reported citation indicators; it does not constitute an independent audit of bibliometric databases or a formal clinical evidence review.

Keywords

Best Paper Award; Paolo Gallo; Medicine and Health Sciences; hepatology; liver cirrhosis; hepatocellular carcinoma; sarcopenia; muscle strength; ultrasonography; bioelectrical impedance analysis; clinical prognostication; research impact.

Introduction

Chronic liver disease can be accompanied by muscle loss and reduced physical strength, factors that may influence clinical outcomes. Reliable screening and prognostic methods are therefore relevant to hepatology research. Ultrasound-based assessment and bioelectrical impedance analysis offer approaches to evaluating body composition, while investigations of muscle strength may help clarify associations with mortality. The supplied publications provide a focused view of these research questions. [1] [2]

Research Profile

The supplied profile identifies Paolo Gallo with Bio-Medico Campus University Hospital in Italy. Reported metrics include 95 documents, 1,878 citations, and an h-index of 25. These indicators describe aspects of publication output and citation activity, but they do not independently establish methodological quality, clinical effectiveness, or the contribution of individual studies. The Scopus author identifier and ORCID provide routes for checking profile information. [3]

Research Contributions

The selected work addresses three connected areas of investigation:

  • Evaluating the relationship between low muscle strength and mortality among patients with liver cirrhosis and hepatocellular carcinoma.
  • Comparing ultrasound and bioelectrical impedance analysis for sarcopenia screening in chronic liver disease.
  • Reviewing ultrasound-based skeletal muscle assessment for prognostication in cirrhosis.

Together, these topics illustrate the importance of measurable clinical indicators and the evaluation of assessment methods in liver disease research. [1] [2] [4]

Publications

  1. “The role of low muscle strength in predicting mortality in patients with liver cirrhosis and hepatocellular carcinoma.” Internal and Emergency Medicine, 16 October 2026. [1]
  2. “Comparative assessment of ultrasound and bioelectrical impedance analysis for sarcopenia screening in chronic liver disease.” Digestive and Liver Disease, October 2026. [2]
  3. “Ultrasound-Based Skeletal Muscle Assessment for Prognostication in Cirrhosis: A Systematic Review.” Liver International, October 2026. [4]

Research Impact

The reported citation count and h-index suggest that the researcher’s publications have accumulated scholarly citations. Their interpretation requires consideration of publication dates, field-specific citation practices, authorship, and database coverage. The selected research themes have potential relevance to clinical assessment and future studies of muscle health in liver disease; practical implications should be determined from the full articles and supporting evidence.

Award Suitability

The Best Paper Award profile aligns with scholarly work in Medicine and Health Sciences through its focus on clinically relevant research questions and assessment methods. The listed publications and bibliometric indicators offer context for evaluating research activity. Final award decisions and claims of formal selection should be confirmed against official award records; this page does not independently verify an award outcome.

Conclusion

Paolo Gallo’s supplied research profile combines established bibliometric indicators with publications addressing sarcopenia, muscle assessment, and outcomes in chronic liver disease. These subjects represent a clinically relevant area of investigation within Medicine and Health Sciences. Author identifiers and DOI links enable further verification of the profile and publication records.

References

  1. “The role of low muscle strength in predicting mortality in patients with liver cirrhosis and hepatocellular carcinoma.” (2026). Internal and Emergency Medicine.
    https://doi.org/10.1007/s11739-026-04548-y
  2. “Comparative assessment of ultrasound and bioelectrical impedance analysis for sarcopenia screening in chronic liver disease.” (2026). Digestive and Liver Disease.
    https://doi.org/10.1016/j.dld.2026.10.009
  3. Elsevier. (n.d.). Scopus author details: Paolo Gallo, Author ID 7101785311. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7101785311
  4. “Ultrasound-Based Skeletal Muscle Assessment for Prognostication in Cirrhosis: A Systematic Review.” (2026). Liver International.
    https://doi.org/10.1111/liv.70891
  5. ORCID. (n.d.). Paolo Gallo researcher identifier.
    https://orcid.org/0000-0001-8292-1134
  6. Global Innovation Technologist Awards. (n.d.). Official award website.
    innovationtechnologist.com

Mahdi Ahmed | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Mahdi Ahmed
University of Liverpool, United Kingdom

                  Mahdi Ahmed
Affiliation University of Liverpool
Country United Kingdom
Documents 2
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0009-0003-2130-2243

The Innovative Research Award profile presents the supplied scholarly information for Mahdi Ahmed, affiliated with the University of Liverpool in the United Kingdom. Associated publication details cover vaccine nanotechnology and cardiovascular mortality research. These subjects connect biomedical investigation with public health priorities, disease prevention and the interpretation of population-level health outcomes. Publication metadata provides a starting point for examining research themes, while independent author-profile verification is necessary to establish attribution and bibliometric performance. [1] [2]

Abstract

This article outlines the supplied research profile and two publications relevant to medicine and health sciences. One examines nanotechnology-enabled vaccines for major infectious diseases, emphasizing translational evidence and implementation in the Global South. The other investigates cardiac arrest and cardiomyopathy-related mortality trends and disparities in the United States from 1999 to 2025. Together, these topics illustrate distinct approaches to health research: developing vaccine technologies and analyzing mortality patterns. The available information does not independently establish authorship, citation totals or award outcomes. [1] [2]

Keywords

Innovative research; medicine and health sciences; nanotechnology-enabled vaccines; infectious diseases; cardiovascular mortality; public health; translational research; health disparities; research evaluation.

Introduction

Biomedical innovation addresses challenges ranging from infectious disease prevention to the assessment of cardiovascular outcomes. Research in these areas may inform vaccine development, health policy and future investigations, although practical benefits depend on the strength of the evidence and subsequent validation. The supplied publications provide a basis for describing these research themes without assuming unverified individual contributions. [1] [2]

Research Profile

The supplied profile identifies Mahdi Ahmed with the University of Liverpool and the United Kingdom. The stated subject area is Medicine and Health Sciences, and the provided ORCID identifier offers a route for checking researcher identity and associated records. Scopus author identification, verified citation totals and h-index information remain unavailable and should be added only after checking authoritative databases.

Research Contributions

The vaccine-focused publication addresses nanotechnology-enabled approaches for malaria, tuberculosis, HIV and dengue, with attention to translational evidence and implementation in the Global South. The cardiovascular study concerns mortality patterns associated with cardiac arrest and cardiomyopathy, including temporal trends and disparities in the United States. These topics represent complementary research priorities, but detailed methods, findings and individual author contributions require review of the full articles. [1] [2]

Publications

  1. Nanotechnology-Enabled Vaccines for Malaria, Tuberculosis, HIV, and Dengue: Translational Evidence and Implementation in the Global South. Nanomaterials, published 20 October 2026. [1]
  2. Cardiac Arrest and Cardiomyopathy Related Mortality in the United States, 1999-2025: Trends and Disparities. ASIDE Cardiovascular, published 3 April 2026. [2]

Research Impact

Potential relevance includes informing research on vaccine delivery and infectious disease prevention, alongside improving understanding of cardiovascular mortality and population disparities. Actual impact should be assessed through verified citations, methodological quality, independent uptake and evidence of clinical or policy application. No citation count or h-index is asserted here because these metrics were not supplied.

Award Suitability

The supplied topics align broadly with the Global Innovation Technologist Awards’ emphasis on research and innovation. A fair assessment for an Innovative Research Award should examine originality, publication quality, methodological rigor, documented contribution and potential societal value. The available metadata supports a preliminary subject-based description, not a confirmed award decision or independently verified evaluation of the named researcher.

Conclusion

The two supplied publications address important questions in infectious disease prevention and cardiovascular public health. Their themes provide a useful starting point for reviewing biomedical research activity. Confirming researcher attribution and assessing individual achievement require verified author records, full-text analysis and reliable bibliometric evidence.

References

  1. Nanomaterials. (2026). Nanotechnology-Enabled Vaccines for Malaria, Tuberculosis, HIV, and Dengue: Translational Evidence and Implementation in the Global South. DOI: 10.3390/nano16201326.
    https://doi.org/10.3390/nano16201326
  2. ASIDE Cardiovascular. (2026). Cardiac Arrest and Cardiomyopathy Related Mortality in the United States, 1999-2025: Trends and Disparities. DOI: 10.71079/ASIDE.CV.040326320.
    https://doi.org/10.71079/ASIDE.CV.040326320
  3. ORCID. (n.d.). Mahdi Ahmed researcher identifier and public profile.
    https://orcid.org/0009-0003-2130-2243
  4. University of Liverpool. (n.d.). Official institutional website.
  5. Elsevier. (n.d.). Scopus abstract and citation database. Researcher metrics and author attribution should be verified against the relevant author record.
  6. Global Innovation Technologist Awards. (n.d.). Official award website and programme information.
    innovationtechnologist.com

Daniel Alfaiate | Medicine and Health Sciences | Best Researcher Award

Published on by Innovation Technologist

Best Researcher Award

Daniel Alfaiate
Instituto Politécnico de Castelo Branco, Portugal

Daniel Alfaiate
Affiliation Instituto Politécnico de Castelo Branco
Country Portugal
Scopus ID 58158006300
Documents 3
Citations 31
h-index 2
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-5581-4242

Daniel Alfaiate is a researcher affiliated with the Instituto Politécnico de Castelo Branco whose documented scholarly activity is situated within Medicine and Health Sciences. The available publication record includes research concerning sleep medicine, obstructive sleep apnea (OSA), electroencephalography, hematological outcomes, and psychotropic medication effects on sleep architecture. Bibliographic information identifies three Scopus documents and 31 citations, with a reported h-index of 2.

Abstract

The research profile of Daniel Alfaiate reflects an emerging focus on clinical and physiological dimensions of sleep and neurological assessment. His documented works address OSA, wakefulness electroencephalography, hematocrit and erythrocytosis, and the effects of psychotropic medication on sleep architecture. These subjects connect diagnostic assessment with clinically relevant sleep outcomes and provide a coherent basis for evaluating research activity in Medicine and Health Sciences. [1]

Keywords

Sleep medicine; obstructive sleep apnea; electroencephalography; polysomnography; sleep architecture; psychotropic medication; hematocrit; erythrocytosis; clinical research.

Introduction

Sleep disorders can involve respiratory, neurological, cardiovascular, and behavioral dimensions, making multidisciplinary clinical research particularly relevant. OSA is associated with measurable physiological changes and may require complementary diagnostic approaches. Research examining wakefulness EEG and hematological characteristics contributes to the broader clinical understanding of patients evaluated for sleep-related disorders. [2] [3]

Research Profile

The available record indicates a focused research trajectory around sleep-related clinical investigation. The profile combines observational clinical work with physiological measurement, including polysomnographic assessment and electroencephalographic evaluation. Bibliometric indicators reported for the researcher include three documents, 31 citations, and an h-index of 2. [1]

Research Contributions

The documented publications address complementary aspects of sleep-related medicine. One study examines the relationship between OSA and hematocrit or erythrocytosis, while another evaluates wakefulness EEG in OSA patients. A later article investigates class-specific and cumulative effects of psychotropic medication on sleep architecture using retrospective polysomnographic data. [2] [3] [4]

Publications

  • Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology, 2026. [4]
  • Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing, 2025. [2]
  • Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing, 2024. [3]
  • Evaluation of wakefulness electroencephalogram in OSA patients. Research Square, 2024. [5]
  • O Eletroencefalograma Emergente nos Cuidados Intensivos. Repositório Científico do Instituto Politécnico de Castelo Branco, 2023. [6]

Research Impact

The reported bibliometric record of 31 citations and an h-index of 2 provides a measurable indication of scholarly visibility. The publications also demonstrate continuity in sleep-related research across 2023–2026, with topics spanning intensive care, OSA assessment, hematological outcomes, and medication-associated changes in sleep architecture. [1]

Award Suitability

For the Best Researcher Award category, the documented record provides evidence of peer-reviewed research activity in a defined medical research area. The combination of recent journal publications, sleep-medicine investigations, and identifiable bibliometric indicators offers an objective basis for consideration. Award assessment should additionally consider authorship roles, methodological quality, peer-review status, broader collaboration, and independent verification of bibliographic records.

Conclusion

Daniel Alfaiate’s documented research activity centers on clinically relevant questions in sleep and neurological assessment. His publications provide a coherent research profile involving OSA, EEG evaluation, hematological outcomes, and polysomnographic investigation. The available bibliometric and publication evidence supports consideration within an academic recognition framework, subject to standard verification procedures.

References

  1. Elsevier. (n.d.). Scopus author details: Daniel Alfaiate, Author ID 58158006300. Scopus.
    https://www.scopus.com/pages/authors/58158006300
  2. Springer Nature. (2025). Impact of obstructive sleep apnea on hematocrit levels and erythrocytosis – a clinical study. Sleep and Breathing.
    DOI: 10.1007/s11325-025-03330-2
  3. Springer Nature. (2024). Evaluation of wakefulness electroencephalogram in OSA patients. Sleep and Breathing.
    DOI: 10.1007/s11325-024-03116-y
  4. Elsevier. (2026). Class-specific and cumulative effects of psychotropic medication on sleep architecture: a polysomnographic retrospective study. European Journal of Pharmacology.
    DOI: 10.1016/j.ejphar.2026.179292
  5. Research Square. (2024). Evaluation of wakefulness electroencephalogram in OSA patients.
    DOI: 10.21203/rs.3.rs-3831506/v1
  6. Instituto Politécnico de Castelo Branco. (2023). O Eletroencefalograma Emergente nos Cuidados Intensivos. Repositório Científico do Instituto Politécnico de Castelo Branco.

Bente Elisabeth Moen | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

 

Innovative Research Award

Bente Elisabeth Moen
University of Bergen, Norway
Bente Elisabeth Moen
Affiliation University of Bergen
Country Norway
Scopus ID 7005903229
Documents 316
Citations 7,639
h-index 45
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
ORCID 0000-0002-0435-3124

The Innovative Research Award recognizes sustained scholarly excellence, research quality, scientific influence, and meaningful contributions to society through evidence-based research. Professor Bente Elisabeth Moen has established an internationally recognized academic profile in occupational medicine, environmental health, and public health research. Her extensive publication record, high citation impact, and interdisciplinary collaborations demonstrate a consistent commitment to improving occupational safety, environmental exposure assessment, and preventive healthcare strategies.[1]

Abstract

Professor Bente Elisabeth Moen has contributed substantially to occupational medicine, workplace epidemiology, environmental exposure research, and preventive health sciences. Her research portfolio includes investigations of pesticide exposure, occupational respiratory health, industrial hygiene, workplace safety culture, and environmental risk assessment. The combination of extensive scholarly productivity and strong citation performance illustrates sustained scientific influence and international research visibility.[1]

Keywords

  • Occupational Medicine
  • Environmental Health
  • Public Health
  • Occupational Epidemiology
  • Industrial Hygiene
  • Preventive Medicine

Introduction

Occupational and environmental health research plays an essential role in protecting workers and improving population well-being. Professor Moen’s investigations have addressed occupational exposure to hazardous substances, respiratory disorders, pesticide exposure, workplace injury prevention, and environmental determinants of health. These studies provide evidence supporting improved occupational policies and preventive interventions across diverse international settings.[2]

Research Profile

With 316 indexed publications, 7,639 citations, and an h-index of 45, Professor Moen demonstrates a sustained record of scientific productivity and scholarly influence. Her collaborations span occupational medicine, environmental epidemiology, public health, and workplace safety, reflecting multidisciplinary engagement with global health challenges.[1]

Research Contributions

  • Occupational exposure assessment.
  • Environmental health epidemiology.
  • Respiratory disease prevention.
  • Pesticide exposure research.
  • Construction workplace safety studies.
  • Global occupational health collaborations.

Publications

  1. Neurodevelopment in children born to women exposed to pesticides during pregnancy. PLOS One (2025).
  2. Occupations and Risk of Head and Neck Cancers: A Case–Control Study in Tanzania. International Journal of Environmental Research and Public Health (2025).
  3. Occupational Pesticide Exposure Risks and Gendered Experiences Among Women in Horticultural Farms in Northern Tanzania.
  4. Reduced lung function among non-smoking workers in the paper industry in Ethiopia.
  5. Association between safety climate, safety participation, safety compliance, and occupational injuries among workers in large-scale building construction projects in Ethiopia.

Research Impact

The research output demonstrates significant international influence through citation performance, interdisciplinary collaboration, and continuous publication in peer-reviewed journals. The work supports evidence-based occupational health policies, workplace safety initiatives, environmental exposure assessment, and preventive medicine.[1]

Award Suitability

Considering the sustained publication record, established citation impact, internationally recognized research profile, and continued contribution to occupational and environmental health sciences, Professor Bente Elisabeth Moen demonstrates qualifications consistent with the objectives of the Global Innovation Technologist Awards. The research portfolio reflects long-term scholarly excellence and measurable scientific impact across multiple areas of medicine and public health.[1]

Conclusion

Professor Bente Elisabeth Moen has developed a distinguished academic career characterized by sustained research productivity, interdisciplinary collaboration, and internationally recognized contributions to occupational and environmental health sciences. Her scholarly achievements, research quality, and measurable scientific influence provide a strong foundation for recognition through the Innovative Research Award.

External Links

References

  1. Scopus Author Profile. Bente Elisabeth Moen. Available at:
    https://www.scopus.com/authid/detail.uri?authorId=7005903229
  2. Moen BE et al. Neurodevelopment in children born to women exposed to pesticides during pregnancy. PLOS One (2025).
    DOI: 10.1371/journal.pone.0326007
  3. Occupations and Risk of Head and Neck Cancers: A Case–Control Study in Tanzania.
    DOI: 10.3390/ijerph22111643
  4. Occupational Pesticide Exposure Risks and Gendered Experiences Among Women in Horticultural Farms in Northern Tanzania.
    DOI: 10.3390/ijerph22101529
  5. Reduced lung function among non-smoking workers in the paper industry in Ethiopia.
    DOI: 10.1007/s00420-025-02163-6
  6. Association between safety climate, safety participation, safety compliance, and occupational injuries among workers in large-scale building construction projects in Ethiopia.
    DOI: 10.1007/s00420-025-02164-5

Gülsüm Kaya | Medicine and Health Sciences | Innovative Research Award

Published on by Innovation Technologist

Innovative Research Award

Gülsüm Kaya
Affiliation Yalova University
Country Turkey
Scopus ID 56589615100
Documents 17
Citations 731
h-index 8
Subject Area Medicine and Health Sciences
Event Global Innovation Technologist Awards
Google Scholar ID d9woUXQAAAAJ

Gülsüm Kaya
Yalova University, Turkey

Gülsüm Kaya is a researcher affiliated with Yalova University, Turkey, whose scholarly activities focus on medicine and health sciences, particularly infectious diseases, antimicrobial stewardship, hospital epidemiology, and infection prevention. Her publication record demonstrates collaborative participation in internationally recognized multicenter investigations addressing healthcare-associated infections, surveillance systems, and evidence-based clinical practice. Through contributions to high-impact journals and multinational research networks, her work supports improved patient safety and infection control strategies in healthcare institutions while advancing scientific understanding of nosocomial infections.[1]

Abstract

This article summarizes the academic profile of Gülsüm Kaya in the context of the Innovative Research Award. Her scholarly contributions encompass infection prevention, antimicrobial utilization, hospital surveillance, and clinical outcomes associated with healthcare-associated infections. Participation in influential international collaborations, including the International Nosocomial Infection Control Consortium (INICC), has contributed to globally cited publications supporting evidence-based infection control practices.[2]

Keywords

Healthcare-associated infections, Infection control, Hospital epidemiology, Antimicrobial stewardship, Nosocomial infections, Clinical microbiology, Patient safety, Medicine and Health Sciences.

Introduction

Modern healthcare systems increasingly rely on multidisciplinary research to reduce infection-related morbidity and improve treatment quality. Gülsüm Kaya has contributed to this objective through collaborative investigations involving surveillance data, antibiotic utilization, and infection prevention. These studies support healthcare policy development and promote standardized approaches to patient safety in hospitals across multiple countries.[3]

Research Profile

According to the supplied scholarly metrics, the researcher has published 17 Scopus-indexed documents, received 731 citations, and achieved an h-index of 8. Her work primarily addresses infectious diseases, antimicrobial therapy, hospital-acquired infections, and epidemiological surveillance. Collaboration with international researchers demonstrates active participation in globally recognized scientific initiatives that generate evidence for healthcare quality improvement.[1]

Research Contributions

Major research contributions include participation in multinational INICC surveillance reports covering dozens of countries, investigations of surgical site infection rates across Turkey, multicenter assessments of antibiotic consumption, and clinical evaluations of antimicrobial therapies for Gram-negative nosocomial infections. These studies provide valuable epidemiological evidence supporting infection control guidelines and healthcare quality assessment.[2]

Publications

  • International Nosocomial Infection Control Consortium report covering 50 countries (2016).
  • INICC device-associated infection report involving 43 countries (2014).
  • Surgical site infection rates across sixteen Turkish cities.
  • Multicenter prevalence study of antibiotic consumption in Turkish hospitals.
  • Clinical outcomes of cefoperazone-sulbactam versus piperacillin-tazobactam therapy.

Research Impact

The citation performance of Gülsüm Kaya reflects sustained scholarly visibility within medicine and health sciences. Highly cited collaborative publications have informed international surveillance practices and strengthened evidence supporting infection prevention initiatives. The combination of clinical relevance, multinational collaboration, and measurable citation impact illustrates meaningful academic influence within the field.[4]

Award Suitability

The research portfolio demonstrates qualities commonly associated with international academic recognition, including collaborative scholarship, publication in peer-reviewed journals, measurable citation impact, and contributions to evidence-based healthcare practice. These characteristics align with the objectives of the Global Innovation Technologist Awards in recognizing research that advances innovation and scientific excellence within medicine and health sciences.[5]

Conclusion

Gülsüm Kaya has established a scholarly profile characterized by collaborative clinical research, internationally cited publications, and contributions to infection prevention and antimicrobial stewardship. Her work supports healthcare quality improvement through evidence generation and multidisciplinary cooperation, making her academic achievements noteworthy within the broader field of medicine and health sciences.[6]

References

  1. Elsevier. (n.d.). Scopus author details: Gülsüm Kaya, Author ID 56589615100.
    https://www.scopus.com/pages/authors/56589615100
  2. Rosenthal VD, et al. (2016). International Nosocomial Infection Control Consortium report. American Journal of Infection Control.
  3. Rosenthal VD, et al. (2014). INICC report: Device-associated module.
    https://doi.org/10.1016/j.ajic.2014.05.029
  4. Leblebicioglu H, et al. (2015). Surgical site infection rates in Turkey.
    https://doi.org/10.1016/j.ajic.2014.08.017
  5. Guclu E, Kaya G, et al. (2020). The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality.
    https://doi.org/10.1080/1120009X.2019.1696735
  6. Guclu E, et al. (2017). Antibiotic consumption in Turkish hospitals.
    https://doi.org/10.1080/1120009X.2016.1235738